Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition

William H D Hallett1, Erik Ames, Milad Motarjemi

  • 1Department of Microbiology and Immunology, University of Nevada School of Medicine, University of Nevada, Reno, NV 89557, USA.

Insights

Bortezomib, a proteasome inhibitor, enhances tumor cell sensitivity to natural killer (NK) cell-mediated killing through TRAIL and FasL pathways. Combining proteasome inhibition with NK cell therapy may improve antitumor efficacy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Pharmacology

Background:

  • Bortezomib is a proteasome inhibitor with direct antitumor effects.
  • Bortezomib can sensitize tumor cells to TRAIL-mediated killing.
  • Natural Killer (NK) cells are potent antitumor effector cells.

Purpose of the Study:

  • To investigate if bortezomib sensitizes tumor cells to NK cell-mediated killing.
  • To elucidate the mechanisms underlying bortezomib's effect on NK cell cytotoxicity.
  • To evaluate the therapeutic potential of combining bortezomib with NK cell therapy.

Main Methods:

  • Tumor cells were preincubated with bortezomib.
  • Short-term and 24-hour NK cell killing assays were performed, including with perforin-deficient NK cells.
  • Tumor outgrowth and tumor purging assays in mice were utilized.
  • Expression of Fas and DR5 on tumor cells was analyzed.

Main Results:

  • Bortezomib alone did not affect short-term NK cell killing.
  • Increased tumor cell killing by perforin-deficient NK cells was observed, dependent on TRAIL and FasL.
  • This correlated with increased Fas and DR5 expression on tumor cells.
  • Combination therapy with bortezomib and NK cells led to significant tumor-free survival in mice.

Conclusions:

  • Bortezomib sensitizes tumor cells to NK cell-mediated killing via TRAIL and FasL pathways.
  • The combination of proteasome inhibition with NK cell therapy demonstrates increased antitumor efficacy.
  • This suggests a promising therapeutic strategy for cancer treatment.

Related Concept Videos

Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...